NFJ Investment Group’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-56
| Closed | -$10.3K | – | 288 |
|
|
2024
Q4 | $10.3K | Hold |
56
| – | – | ﹤0.01% | 266 |
|
|
2024
Q3 | $11K | Sell |
56
-28,192
| -100% | -$5.55M | ﹤0.01% | 267 |
|
|
2024
Q2 | $5.84M | Sell |
28,248
-3,817
| -12% | -$789K | 0.18% | 125 |
|
|
2024
Q1 | $8.69M | Sell |
32,065
-6,452
| -17% | -$1.75M | 0.24% | 114 |
|
|
2023
Q4 | $9.11M | Sell |
38,517
-6,779
| -15% | -$1.6M | 0.25% | 108 |
|
|
2023
Q3 | $8.88M | Sell |
45,296
-513
| -1% | -$101K | 0.26% | 99 |
|
|
2023
Q2 | $9.63M | Buy |
45,809
+65
| +0.1% | +$13.7K | 0.26% | 115 |
|
|
2023
Q1 | $9.23M | Sell |
45,744
-504
| -1% | -$102K | 0.25% | 130 |
|
|
2022
Q4 | $10.1M | Sell |
46,248
-24,291
| -34% | -$5.29M | 0.26% | 123 |
|
|
2022
Q3 | $11.4M | Buy |
+70,539
| New | +$11.4M | 0.3% | 119 |
|